Bright Minds Biosciences (DRUG) EBIT (2023 - 2024)
Bright Minds Biosciences (DRUG) reported EBIT of $32422.2 for Q4 2024, up 102.62% on a YoY basis from $16001.4 in Q1 2024, and down 79.37% quarter-over-quarter from $157133.8 in Q2 2024.
Bright Minds Biosciences (DRUG) EBIT (2023 - 2024) Analysis & Trends
Bright Minds Biosciences has reported EBIT for 2 years, with the latest figure at $32422.2 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -65.83 Mn |
| 10 | Bright Minds Biosciences | 16.28 Bn | 16.22 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 32,422.24 |
| Jun 30, 2024 | 157,133.80 |
| Dec 31, 2023 | -1.24 Mn |
| Jun 30, 2023 | -1.09 Mn |